HMOX1 and Parkinson disease: A postmortem study demonstrated that a fraction of GFAP-positive astrocytes expressed HO-1 in the substantia nigra of PD patients (77.1 ± 12.3) at a level that was significantly greater than that observed in the substantia nigra of control subjects (18.7 ± 7.1; P = 0.0015).